| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Does conventional anti-bipolar and antidepressant drug therapy reduce NMDA-mediated neuronal excitation by downregulating astrocytic GluK2 function?
|
Peng, Liang
|
|
2012
|
100 |
4 |
p. 712-725
14 p.
|
artikel
|
| 2 |
Editorial Board
|
|
|
2012
|
100 |
4 |
p. IFC-
1 p.
|
artikel
|
| 3 |
Expression profiling in neuropsychiatric disorders: Emphasis on glutamate receptors in bipolar disorder
|
Ginsberg, Stephen D.
|
|
2012
|
100 |
4 |
p. 705-711
7 p.
|
artikel
|
| 4 |
Glutamate mediated signaling in the pathophysiology of autism spectrum disorders
|
Choudhury, Paromita Roy
|
|
2012
|
100 |
4 |
p. 841-849
9 p.
|
artikel
|
| 5 |
Glutamate, obsessive–compulsive disorder, schizophrenia, and the stability of cortical attractor neuronal networks
|
Rolls, Edmund T.
|
|
2012
|
100 |
4 |
p. 736-751
16 p.
|
artikel
|
| 6 |
Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders
|
Carlson, Greg C.
|
|
2012
|
100 |
4 |
p. 850-854
5 p.
|
artikel
|
| 7 |
Glutamate receptors in preclinical research on Alzheimer's disease: Update on recent advances
|
Hu, Neng-Wei
|
|
2012
|
100 |
4 |
p. 855-862
8 p.
|
artikel
|
| 8 |
Glutamate receptors — Prenatal insults, long-term consequences
|
Griesmaier, Elke
|
|
2012
|
100 |
4 |
p. 835-840
6 p.
|
artikel
|
| 9 |
Glutamatergic medications for the treatment of drug and behavioral addictions
|
Olive, M. Foster
|
|
2012
|
100 |
4 |
p. 801-810
10 p.
|
artikel
|
| 10 |
Glutamate signaling in the pathophysiology and therapy of prenatal insults
|
Holopainen, Irma E.
|
|
2012
|
100 |
4 |
p. 825-834
10 p.
|
artikel
|
| 11 |
Glutamate signaling in the pathophysiology and therapy of schizophrenia
|
Lin, Chieh-Hsin
|
|
2012
|
100 |
4 |
p. 665-677
13 p.
|
artikel
|
| 12 |
Guest Editorial
|
Siegel, Steve
|
|
2012
|
100 |
4 |
p. 653-655
3 p.
|
artikel
|
| 13 |
Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: Focus on pharmacology and preclinical translational models
|
Harvey, Brian H.
|
|
2012
|
100 |
4 |
p. 775-800
26 p.
|
artikel
|
| 14 |
New perspectives in glutamate and anxiety
|
Riaza Bermudo-Soriano, Carlos
|
|
2012
|
100 |
4 |
p. 752-774
23 p.
|
artikel
|
| 15 |
Novel glutamatergic agents for major depressive disorder and bipolar disorder
|
Machado-Vieira, Rodrigo
|
|
2012
|
100 |
4 |
p. 678-687
10 p.
|
artikel
|
| 16 |
Overview of glutamatergic neurotransmission in the nervous system
|
Niciu, Mark J.
|
|
2012
|
100 |
4 |
p. 656-664
9 p.
|
artikel
|
| 17 |
Roles of glutamate signaling in preclinical and/or mechanistic models of depression
|
Tokita, Kenichi
|
|
2012
|
100 |
4 |
p. 688-704
17 p.
|
artikel
|
| 18 |
Special issue title page
|
|
|
2012
|
100 |
4 |
p. iii-
1 p.
|
artikel
|
| 19 |
The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder
|
Wu, Ke
|
|
2012
|
100 |
4 |
p. 726-735
10 p.
|
artikel
|
| 20 |
The role of metabotropic glutamate receptors in addiction: Evidence from preclinical models
|
Duncan, Jhodie R.
|
|
2012
|
100 |
4 |
p. 811-824
14 p.
|
artikel
|
Tijdschrift beschrijving